-
1
-
-
0031014450
-
Cancer statistics, 1997
-
Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
-
(1997)
CA Cancer J Clin
, vol.47
, pp. 5-27
-
-
Parker, S.L.1
Tong, T.2
Bolden, S.3
-
2
-
-
0026721532
-
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
-
The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
-
(1992)
J Clin Oncol
, vol.10
, pp. 896-903
-
-
-
4
-
-
0019399125
-
New natural products under development at the National Cancer Institute
-
Douros J, Suffness M. New natural products under development at the National Cancer Institute. Recent Results Cancer Res 1981;76:153-75.
-
(1981)
Recent Results Cancer Res
, vol.76
, pp. 153-175
-
-
Douros, J.1
Suffness, M.2
-
5
-
-
0026767740
-
Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells
-
Hanauske A-R, Degen D, Hilsenbeck SG, et al. Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anti-Cancer Drugs 1992;3:121-4.
-
(1992)
Anti-Cancer Drugs
, vol.3
, pp. 121-124
-
-
Hanauske, A.-R.1
Degen, D.2
Hilsenbeck, S.G.3
-
6
-
-
0027791909
-
Taxol-base combination chemotherapy and other in vivo preclinical antitumor studies
-
Rose WC. Taxol-base combination chemotherapy and other in vivo preclinical antitumor studies. Monogr Natl Cancer Inst 1993;15:47-53.
-
(1993)
Monogr Natl Cancer Inst
, vol.15
, pp. 47-53
-
-
Rose, W.C.1
-
7
-
-
0029622442
-
Cytotoxicity of paclitaxel in comparison with other anticancer agents against neoplastic cells obtained from clinical gastrointestinal carcinoma tissue
-
Matsuoka H, Yano K, Saito T, et al. Cytotoxicity of paclitaxel in comparison with other anticancer agents against neoplastic cells obtained from clinical gastrointestinal carcinoma tissue. Anticancer Res 1995;15:2001-6.
-
(1995)
Anticancer Res
, vol.15
, pp. 2001-2006
-
-
Matsuoka, H.1
Yano, K.2
Saito, T.3
-
8
-
-
0023261546
-
Phase I clinical and pharmacokinetic study of taxol
-
Wiernik PH, Schwartz EL, Strauman JJ, et al. Phase I clinical and pharmacokinetic study of taxol. Cancer Res 1987;47:2946-93.
-
(1987)
Cancer Res
, vol.47
, pp. 2946-2993
-
-
Wiernik, P.H.1
Schwartz, E.L.2
Strauman, J.J.3
-
9
-
-
0026723301
-
Taxol: The first of the taxanes, an important new class of antitumor agents
-
Rowinsky EK, Onetto N, Canetta RM, et al. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 1992;19:646-62.
-
(1992)
Semin Oncol
, vol.19
, pp. 646-662
-
-
Rowinsky, E.K.1
Onetto, N.2
Canetta, R.M.3
-
10
-
-
0027238859
-
Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
-
Lopes NM, Adams EG, Petts TW, et al. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 1993;32:235-42.
-
(1993)
Cancer Chemother Pharmacol
, vol.32
, pp. 235-242
-
-
Lopes, N.M.1
Adams, E.G.2
Petts, T.W.3
-
11
-
-
0042132423
-
Expression of a multidrug resistance gene in human tumors and tissues
-
Fojo AT, Ueda K, Slamon DJ, et al. Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-9.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 265-269
-
-
Fojo, A.T.1
Ueda, K.2
Slamon, D.J.3
-
12
-
-
0026050325
-
P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines
-
Lai GM, Chen YN, Mickley LA, et al. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines. Int J Cancer 1991;49:696-703.
-
(1991)
Int J Cancer
, vol.49
, pp. 696-703
-
-
Lai, G.M.1
Chen, Y.N.2
Mickley, L.A.3
-
13
-
-
0025115739
-
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
-
Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:7160-4.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 7160-7164
-
-
Noonan, K.E.1
Beck, C.2
Holzmayer, T.A.3
-
14
-
-
0028110931
-
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: A phase I/II trial of 96-hr infusion
-
Wilson WH, Berg S, Bryant G, et al. Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hr infusion. J Clin Oncol 1994;12:1621-9.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1621-1629
-
-
Wilson, W.H.1
Berg, S.2
Bryant, G.3
-
15
-
-
0028817461
-
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas
-
Wilson WH, Chabner BA, Bryant G, et al. Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. J Clin Oncol 1995;13:381-6.
-
(1995)
J Clin Oncol
, vol.13
, pp. 381-386
-
-
Wilson, W.H.1
Chabner, B.A.2
Bryant, G.3
-
16
-
-
0029946928
-
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: A phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
-
Seidman AD, Hochhauser D, Gollub M, et al. Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. J Clin Oncol 1996;14:1877-84.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1877-1884
-
-
Seidman, A.D.1
Hochhauser, D.2
Gollub, M.3
-
17
-
-
0027954464
-
Taxol metabolism by human liver microsomes: Identification of cytochrome P-450 isozymes involved in its biotransformation
-
Cresteil T, Monsarrat B, Alvinerie P, et al. Taxol metabolism by human liver microsomes: identification of cytochrome P-450 isozymes involved in its biotransformation. Cancer Res 1994;54:386-92.
-
(1994)
Cancer Res
, vol.54
, pp. 386-392
-
-
Cresteil, T.1
Monsarrat, B.2
Alvinerie, P.3
-
18
-
-
0027137936
-
Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model
-
Sharma A, Mayhew E, Straubinger RM. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res 1993;53:5877-81.
-
(1993)
Cancer Res
, vol.53
, pp. 5877-5881
-
-
Sharma, A.1
Mayhew, E.2
Straubinger, R.M.3
-
19
-
-
10144251769
-
Syntheses and structure-activity relationships of the second-generation antitumor taxoids: Exceptional activity against drug-resistant cancer cells
-
Ojima I, Slater JC, Michaud E, et al. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. J Med Chem 1996;39:3889-96.
-
(1996)
J Med Chem
, vol.39
, pp. 3889-3896
-
-
Ojima, I.1
Slater, J.C.2
Michaud, E.3
-
20
-
-
0029919598
-
Irinotecan (CPT-11) is an active agent in untreated patients with metastatic colorectal cancer
-
Conti JA, Kemeny N, Saltz L, et al. Irinotecan (CPT-11) is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol 1996;14:709-15.
-
(1996)
J Clin Oncol
, vol.14
, pp. 709-715
-
-
Conti, J.A.1
Kemeny, N.2
Saltz, L.3
-
21
-
-
0029931840
-
Tomudex: A novel thymidylate synthase inhibitor with clinical antitumor activity in a range of solid tumors
-
Cunningham D, Zalcberg J, Smith IE, et al. Tomudex: a novel thymidylate synthase inhibitor with clinical antitumor activity in a range of solid tumors. Ann Oncol 1996;7:179-82.
-
(1996)
Ann Oncol
, vol.7
, pp. 179-182
-
-
Cunningham, D.1
Zalcberg, J.2
Smith, I.E.3
-
22
-
-
0031051207
-
Adjuvant treatment of colorectal cancer
-
Saltz LB, Kelsen DP. Adjuvant treatment of colorectal cancer. Annu Rev Med 1997;48:191-202.
-
(1997)
Annu Rev Med
, vol.48
, pp. 191-202
-
-
Saltz, L.B.1
Kelsen, D.P.2
|